Obesity, islet cell autoimmunity, and cardiovascular risk factors in youth at onset of type 1 autoimmune diabetes

Journal of Clinical Endocrinology and Metabolism

Volumn 100, Issue 1, 2015, Pages E82-E86

  Cedillo, Maribel ^a   Libman, Ingrid M ^a   Arena, Vincent C ^b   Zhou, Lei ^b   Trucco, Massimo ^a   Ize Ludlow, Diego ^c   Pietropaolo, Massimo ^d   Becker, Dorothy J ^a  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^d UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; C PEPTIDE; HEMOGLOBIN A1C;

ADOLESCENT; ADULT; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; BODY MASS; CARDIOVASCULAR RISK; CHILD; CHILDHOOD OBESITY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; ISLET CELL AUTOIMMUNITY; JUVENILE; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PANCREAS ISLET CELL; PRESCHOOL CHILD; PREVALENCE; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SCHOOL CHILD; SCORING SYSTEM; WAIST CIRCUMFERENCE; WAIST TO HEIGHT RATIO; YOUNG ADULT; Z SCORE; CARDIOVASCULAR DISEASES; COMPLICATION; IMMUNOLOGY; INFANT; OBESITY; PANCREAS ISLET;

ADOLESCENT; AUTOANTIBODIES; AUTOIMMUNITY; BODY MASS INDEX; CARDIOVASCULAR DISEASES; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; INFANT; ISLETS OF LANGERHANS; MALE; OBESITY; PROSPECTIVE STUDIES; RISK FACTORS; WAIST CIRCUMFERENCE;

EID: 84920587132     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2014-2340     Document Type: Article

References (20)

1. Ogden CL, Carroll MD, Kit BK, Flegal KM. Prevalence of obesity and trends in body mass index among US children and adolescents, 1999-2010. JAMA. 2012;307(5):483-490.
2. Prentice AM. The emerging epidemic of obesity in developing countries. Int J Epidemiol. 2006;35(1):93-99.
3. Libman IM, Pietropaolo M, Arslanian SA, LaPorte RE, Becker DJ. Changing prevalence o f overweight childrenandadolescents at onset of insulin-treated diabetes. Diabetes Care. 2003;26(10):2871-2875.
4. Libman IM, Balfour P, Brooke S, LaPorte RE, Becker DJ. Alarming continu ed increase of overweight at onset of insulin-treated diabetes in both African-American and Caucasian children. Diabetologia. 2006;49(suppl1):OP0175.
5. Kaminski BM, Klingensmith GJ, Beck RW, et al. Body mass index at the time of diagnosis of autoimmune type 1 diabetes in children. J Pediatr. 2013;162(4):736-740.e1.
6. Dabelea D, Bell RA, D'Agostino RB Jr., et al. Incidence of diabetes in youth in the United States. JAMA. 2007;297(24):2716-2724.
7. Patterson C, Dahlquist G, Gyürüs EvaGASoltész Gyula, EURODIAB Study Group. Incidence trends for childhood type 1 diabetes in Europe during 1989-2003 and predicted new cases 2005-20: a multicentre prospective registration study. Lancet. 2009;373:2027-2033.
8. Gardner SG,Bingley PJ,Sawtell PA,Weeks S,Gale EA. Rising incidence of insulin dependent diabetes in children aged under 5 years in the Oxford region: time trend analysis BMJ. 1997 713-717.
9. Schoenle EJ, Lang-Muritano M, Gschwend S, et al. Epidemiology of type I diabetes mellitus in Switzerland: steep rise in incidence in under 5 year old children in the past decade. Diabetologia. 2001; 44(3):286-289.
10. Libman IM, Pietropaolo M, Arslanian SA, LaPorte RE, Becker DJ. Evidence for heterogeneous pathogenesis of insulin-treated diabetes in black and white children. Diabetes Care. 2003;26(10):2876-2882.
11. Gale EA. To b oldly go-or to go too boldly? The accelerator hypothesis revisited. Diabetologia. 2007;50(8):1571-1575.
12. Wilkin TJ. The accelerator hypothesis: weight gain as the missing link between type I and type II diabetes. Diabetologia. 2001;44(7): 914-922.
13. Libman IM, Becker DJ. Coexistence of type 1 and type 2 diabetes mellitus: " double" diabetes? Pediatr Diabetes. 2003;4(2):110-113.
14. Porter JR, Barrett TG. Braking the accelerator hypothesis? Diabetologia. 2004;47(2):352-353.
15. Bingley PJ, Mahon JL, Gale EA. Insulin resistance and progression to type 1 diabetes in the European Nicotinamide Diabetes Intervention Trial (ENDIT). Diabetes Care. 2008;31(1):146-150.
16. Mokha JS, Srinivasan SR, DasMahapatra P, et al. Utility of waistto-height ratio in assessing the status of central obesity and related cardiometabolic risk profile among normal weight and overweight/obese children: The Boga lusa Heart Study. BMC Pediatr. 2010; 10(1):73.
17. Fernández JR, Redden DT, Pietrobelli A, Allison DB. Waist circumference percentiles in nationally representative samples of African-American, E uropean-American, and Mexican-American children and adolescents. J Pediatr. 2004;145(4):439-444.
18. Ringquist S, Bellone G, Lu Y, Trucco M. Transplantation Genetics. Emery and Rimoin's Principles and Practice of Medical Genetics. 6th ed. Philadelphia, PA: Elsevier; 2013.
19. Orchard TJ, Olson JC, Erbey JR, et al. Insulin Resistance-related factors, but not glycemia, predict coronary artery disease in type1diabetes 10-year follow-up data from the Pittsburgh Epidemiology of Diabetes Complications study. Diabetes Care. 2003;26(5):1374-1379.
20. Kilpatrick ES, Rigby AS, Atkin SL. Insulin resistance, the metabolic syndrome, and complication risk in type 1 diabetes "double diabetes" in the Diabetes Control and Complications Trial. Diabetes Care. 2007;30(3):707-712.